BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

964 related articles for article (PubMed ID: 17381617)

  • 21. AABB survey of transfusion-related acute lung injury policies and practices in the United States.
    Kopko P; Silva M; Shulman I; Kleinman S
    Transfusion; 2007 Sep; 47(9):1679-85. PubMed ID: 17725734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The residual risk of transfusion-related acute lung injury at the American Red Cross (2008-2011): limitations of a predominantly male-donor plasma mitigation strategy.
    Eder AF; Dy BA; Perez JM; Rambaud M; Benjamin RJ
    Transfusion; 2013 Jul; 53(7):1442-9. PubMed ID: 23113676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis of transfusion-related acute lung injury: TRALI or not TRALI?
    Fontaine MJ; Malone J; Mullins FM; Grumet FC
    Ann Clin Lab Sci; 2006; 36(1):53-8. PubMed ID: 16501237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of transfusion-related acute lung injury (TRALI): anti-leukocyte antibodies.
    Curtis BR; McFarland JG
    Crit Care Med; 2006 May; 34(5 Suppl):S118-23. PubMed ID: 16617255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicted effect of selectively testing female donors for HLA antibodies to mitigate transfusion-related acute lung injury risk from apheresis platelets.
    Eder AF; Dy BA; O'Neill EM
    Transfusion; 2016 Jun; 56(6 Pt 2):1608-15. PubMed ID: 26830063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004-2006).
    Eder AF; Kennedy JM; Dy BA; Notari EP; Weiss JW; Fang CT; Wagner S; Dodd RY; Benjamin RJ;
    Transfusion; 2007 Jul; 47(7):1134-42. PubMed ID: 17581147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute lung injury after ruptured abdominal aortic aneurysm repair: the effect of excluding donations from females from the production of fresh frozen plasma.
    Wright SE; Snowden CP; Athey SC; Leaver AA; Clarkson JM; Chapman CE; Roberts DR; Wallis JP
    Crit Care Med; 2008 Jun; 36(6):1796-802. PubMed ID: 18496377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A touch of TRALI.
    Davis A; Mandal R; Johnson M; Makar R; Stowell C; Dzik S
    Transfusion; 2008 Mar; 48(3):541-5. PubMed ID: 18067496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A national survey of transfusion-related acute lung injury risk reduction policies for platelets and plasma in the United States.
    Kleinman S; Grossman B; Kopko P
    Transfusion; 2010 Jun; 50(6):1312-21. PubMed ID: 20456690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conversion to low transfusion-related acute lung injury (TRALI)-risk plasma significantly reduces TRALI.
    Arinsburg SA; Skerrett DL; Karp JK; Ness PM; Jhang J; Padmanabhan A; Gibble J; Schwartz J; King KE; Cushing MM
    Transfusion; 2012 May; 52(5):946-52. PubMed ID: 22060800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood donor and component management strategies to prevent transfusion-related acute lung injury (TRALI).
    Mair DC; Hirschler N; Eastlund T
    Crit Care Med; 2006 May; 34(5 Suppl):S137-43. PubMed ID: 16617258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transfusion-related acute lung injury: reports to the French Hemovigilance Network 2007 through 2008.
    Ozier Y; Muller JY; Mertes PM; Renaudier P; Aguilon P; Canivet N; Fabrigli P; Rebibo D; Tazerout M; Trophilme C; Willaert B; Caldani C
    Transfusion; 2011 Oct; 51(10):2102-10. PubMed ID: 21382042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrent transfusion-related acute lung injury after a two-year interval.
    Krochmal JD; Dwyre DM; Swanson KM; Raife TJ; Schlueter AJ
    Transfus Med; 2007 Jun; 17(3):192-6. PubMed ID: 17561861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of fresh-frozen plasma from male-only donors versus mixed-sex donors on postoperative respiratory function in surgical patients: a prospective case-controlled study.
    Nakazawa H; Ohnishi H; Okazaki H; Hashimoto S; Hotta H; Watanabe T; Ohkawa R; Yatomi Y; Nakajima K; Iwao Y; Takamoto S; Shimizu M; Iijima T
    Transfusion; 2009 Nov; 49(11):2434-41. PubMed ID: 19624605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recipients of blood from a donor with multiple HLA antibodies: a lookback study of transfusion-related acute lung injury.
    Toy P; Hollis-Perry KM; Jun J; Nakagawa M
    Transfusion; 2004 Dec; 44(12):1683-8. PubMed ID: 15584980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. White blood cell-reactive antibodies are undetectable in solvent/detergent plasma.
    Sachs UJ; Kauschat D; Bein G
    Transfusion; 2005 Oct; 45(10):1628-31. PubMed ID: 16181214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TRALI risk reduction: donor and component management strategies.
    Eder AF; Benjamin RJ
    J Clin Apher; 2009; 24(3):122-9. PubMed ID: 19365816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The practice of reporting transfusion-related acute lung injury: a national survey among clinical and preclinical disciplines.
    Vlaar AP; Wortel K; Binnekade JM; van Oers MH; Beckers E; Gajic O; Schultz MJ; Juffermans NP
    Transfusion; 2010 Feb; 50(2):443-51. PubMed ID: 19804567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transfusion-related acute lung injury: a preventable syndrome?
    Müller MC; Juffermans NP
    Expert Rev Hematol; 2012 Feb; 5(1):97-106. PubMed ID: 22272709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-risk transfusion-related acute lung injury donor strategies and the impact on the onset of transfusion-related acute lung injury: a meta-analysis.
    Müller MC; van Stein D; Binnekade JM; van Rhenen DJ; Vlaar AP
    Transfusion; 2015 Jan; 55(1):164-75. PubMed ID: 25135630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.